Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib

Abstract Purpose Metastatic gastrointestinal stromal tumour (GIST) is generally an incurable disease with variable response to imatinib. We aimed to develop prognostic nomograms to predict overall survival (OS) and progression-free survival (PFS) for patients treated with imatinib. Methods Nomograms...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2015-05, Vol.51 (7), p.852-860
Hauptverfasser:	Lee, Chee Khoon, Goldstein, David, Gibbs, Emma, Joensuu, Heikki, Zalcberg, John, Verweij, Jaap, Casali, Paolo G, Maki, Robert G, Cioffi, Angela, Mcarthur, Grant, Lord, Sarah J, Yip, Desmond, Kanjanapan, Yada, Rutkowski, Piotr
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Benzamides - therapeutic use Female Gastrointestinal Neoplasms - diagnosis Gastrointestinal Neoplasms - drug therapy Gastrointestinal Neoplasms - mortality Gastrointestinal Neoplasms - pathology Gastrointestinal Stromal Tumors - diagnosis Gastrointestinal Stromal Tumors - drug therapy Gastrointestinal Stromal Tumors - mortality Gastrointestinal Stromal Tumors - pathology Gastrointestinal stromal tumour Hematology, Oncology and Palliative Medicine Humans Imatinib Imatinib Mesylate Male Middle Aged Neoplasm Metastasis Nomogram Nomograms Piperazines - therapeutic use Prognosis Pyrimidines - therapeutic use Survival Analysis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!